XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 47,152 $ 103,172
Accounts receivable, less allowance of $1,114 and $973, respectively 183,476 185,058
Inventory:    
Raw materials 61,770 64,175
Work in process 6,671 16,139
Finished goods 40,148 41,095
Inventory, net 108,589 121,409
Derivative financial instruments 1,299 213
Prepaid expenses and other assets 57,846 51,217
Assets held for sale 56,184  
Total current assets 454,546 461,069
Property and equipment, net 189,005 200,294
Goodwill 55,705 69,685
Other intangible assets, net 60,202 83,286
Deferred financing costs 733 936
Deferred income tax assets 73,221 30,152
Other non-current assets 11,617 37,983
Total assets 845,029 883,405
Current Liabilities:    
Accounts payable 88,991 89,596
Accrued liabilities 72,544 77,209
Current maturities of long-term debt 3,429 3,460
Derivative financial instruments   1,050
Liabilities held for sale 13,473  
Total current liabilities 178,437 171,315
Pension benefit obligation 7,312 7,913
Other liabilities 7,488 2,747
Long-term debt, less current maturities 98,000 141,209
Deferred income tax liabilities 3,471 6,347
Total liabilities 294,708 329,531
Common Stock:    
No par value; 55,000,000 shares authorized, 35,748,829 and 36,761,362 issued and outstanding at September 30, 2018 and December 31, 2017, respectively 218,569 265,048
Paid-in capital 14,293 15,625
Accumulated other comprehensive loss (33,877) (20,444)
Accumulated earnings 351,336 293,645
Total shareholders’ equity 550,321 553,874
Total liabilities and shareholders’ equity $ 845,029 $ 883,405